These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26228860)

  • 1. [Cancer genetic counseling and quality of life: the effect of coping strategies and psychopathological symptoms during pre-test genetic counseling].
    Di Mattei VE; Duchini E; Zucchi P; Patricelli MG; Rognone A; Di Pierro R; Zambetti M; Sarno L
    Recenti Prog Med; 2015 Aug; 106(8):380-4. PubMed ID: 26228860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer.
    Cicero G; De Luca R; Dorangricchia P; Lo Coco G; Guarnaccia C; Fanale D; Calò V; Russo A
    J Genet Couns; 2017 Oct; 26(5):999-1007. PubMed ID: 28283917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer.
    Nordin K; Lidén A; Hansson M; Rosenquist R; Berglund G
    J Med Genet; 2002 Sep; 39(9):689-94. PubMed ID: 12205115
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K
    Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial consequences of genetic counseling: a population-based follow-up study.
    Mikkelsen EM; Sunde L; Johansen C; Johnsen SP
    Breast J; 2009; 15(1):61-8. PubMed ID: 19120380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory study.
    Catania C; Feroce I; Barile M; Goldhirsch A; De Pas T; de Braud F; Boselli S; Adamoli L; Radice D; Rossi A; Spitaleri G; Noberasco C; Bonanni B
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):633-48. PubMed ID: 26577826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
    Arver B; Haegermark A; Platten U; Lindblom A; Brandberg Y
    Fam Cancer; 2004; 3(2):109-16. PubMed ID: 15340261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal.
    Audrain J; Schwartz MD; Lerman C; Hughes C; Peshkin BN; Biesecker B
    Ann Behav Med; 1997; 19(4):370-7. PubMed ID: 9706364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
    Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
    Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk.
    Tercyak KP; Lerman C; Peshkin BN; Hughes C; Main D; Isaacs C; Schwartz MD
    Health Psychol; 2001 May; 20(3):217-22. PubMed ID: 11403219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer.
    Lobb E; Meiser B
    Lancet; 2004 Jun; 363(9424):1841-2. PubMed ID: 15183619
    [No Abstract]   [Full Text] [Related]  

  • 18. The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample.
    Caruso A; Vigna C; Maggi G; Sega FM; Cognetti F; Savarese A
    J Exp Clin Cancer Res; 2008 Nov; 27(1):75. PubMed ID: 19025627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
    Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
    Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.